Frontiers in Immunology (Dec 2021)

Vulnerability to Meningococcal Disease in Immunodeficiency Due to a Novel Pathogenic Missense Variant in NFKB1

  • Manfred Anim,
  • Manfred Anim,
  • Georgios Sogkas,
  • Georgios Sogkas,
  • Gunnar Schmidt,
  • Natalia Dubrowinskaja,
  • Torsten Witte,
  • Reinhold Ernst Schmidt,
  • Reinhold Ernst Schmidt,
  • Faranaz Atschekzei,
  • Faranaz Atschekzei

DOI
https://doi.org/10.3389/fimmu.2021.767188
Journal volume & issue
Vol. 12

Abstract

Read online

NF-κB1 deficiency is suggested to be the most common cause of common variable immunodeficiency (CVID). NFKB1 encodes for the p105 precursor protein of NF-κB1, which is converted into the active transcriptional subunit p50 through proteasomal processing of its C-terminal half upon stimulation and is implicated in the canonical NF-kB pathway. Rare monoallelic NFKB1 variants have been shown to cause (haplo) insufficiency. Our report describes a novel NFKB1 missense variant (c.691C>T, p.R230C; allele frequency 0.00004953) in a family vulnerable to meningitis, sepsis, and late-onset hypogammaglobulinemia. We investigated the pathogenic relevance of this variant by lymphocyte stimulation, immunophenotyping, overexpression study and immunoblotting. The ectopic expression of p50 for c.691 C>T restricted transcriptionally active p50 in the cytoplasm, and immunoblotting revealed reduced p105/50 expression. This study shows that the deleterious missense variant in NFKB1 adversely affects the transcriptional and translational activity of NFκB1, impairing its function. Patients immunological parameters show a progressive course of hypogammaglobulinemia, which may partially account for the incomplete disease penetrance and suggest the need for closer immunological monitoring of those mutation carriers.

Keywords